Copyright
©The Author(s) 2024.
World J Hepatol. Jan 27, 2024; 16(1): 41-53
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.41
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.41
Figure 1 Flow chart of patients included in this study.
HCV: Hepatitis C virus; HCC: hepatocellular carcinoma; DAA: Direct-Acting Antiviral Agents; SVR: sustained virologic response; PSM: propensity score matching.
- Citation: Tao XM, Zeng MH, Zhao YF, Han JX, Mi YQ, Xu L. Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study. World J Hepatol 2024; 16(1): 41-53
- URL: https://www.wjgnet.com/1948-5182/full/v16/i1/41.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i1.41